Cargando…
What is the Role of the Bystander Response in Radionuclide Therapies?
Radionuclide therapy for cancer is undergoing a renaissance, with a wide range of radionuclide and clinical delivery systems currently under investigation. Dosimetry at the cellular and sub-cellular level is complex with inhomogeneity and incomplete targeting of all cells such that some tumor cells...
Autores principales: | Brady, Darren, O’Sullivan, Joe M., Prise, Kevin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746502/ https://www.ncbi.nlm.nih.gov/pubmed/23967404 http://dx.doi.org/10.3389/fonc.2013.00215 |
Ejemplares similares
-
The Role of Bystander Effects in the Antitumor Activity of the Hypoxia-Activated Prodrug PR-104
por: Foehrenbacher, Annika, et al.
Publicado: (2013) -
Prospects in Folate Receptor-Targeted Radionuclide Therapy
por: Müller, Cristina, et al.
Publicado: (2013) -
Differential responses to (223)Ra and Alpha-particles exposure in prostate cancer driven by mitotic catastrophe
por: Guerra Liberal, Francisco D. C., et al.
Publicado: (2022) -
Radioprotection of targeted and bystander cells by methylproamine
por: Burdak-Rothkamm, Susanne, et al.
Publicado: (2014) -
The Roles of HIF-1α in Radiosensitivity and Radiation-Induced Bystander Effects Under Hypoxia
por: Zhang, Jianghong, et al.
Publicado: (2021)